David S Liebeskind (@dliebesk) 's Twitter Profile
David S Liebeskind

@dliebesk

Neurovascular

ID: 21123419

linkhttp://www.collateralperfusion.org calendar_today17-02-2009 19:56:59

239 Tweet

1,1K Followers

124 Following

BRAIN Conference (@brainconferenc1) 's Twitter Profile Photo

🎉Registration for the fifth annual #BRAINConference is officially open! 👉Secure your spot today to join us in person or online at etc.venues 155 Bishopsgate, London, on 2-4 December 2024 🧠Topics include #stroke, #aneurysms, new technology and much more!

🎉Registration for the fifth annual #BRAINConference is officially open!

👉Secure your spot today to join us in person or online at <a href="/etcvenues/">etc.venues</a> 155 Bishopsgate, London, on 2-4 December 2024

🧠Topics include #stroke, #aneurysms, new technology and much more!
Tudor G. Jovin, MD (@tudorgjovin) 's Twitter Profile Photo

Humbled to have co-led this trial showing benefit of MT in early presenting pts with unlimitedly large infarcts. Large core regardless of size = poor prognosis, but not treatment effect modifier. IMAGING CANNOT IDENTIFY PTS WHO DON'T BENEFIT FROM MT !! nejm.org/doi/full/10.10…

Gravity Medical Technology (@gravitymedtech) 's Twitter Profile Photo

Congrats to Dr. Tudor G. Jovin, MD & Dr. David S Liebeskind, MD, MBA on the LASTE trial publication! Large core strokes of unrestricted size receiving thrombectomy have favorable patient outcomes to medical care alone. This reinforces the need to increase accessible Thrombectomy worldwide #LASTETrial

Congrats to Dr. <a href="/TudorGJovin/">Tudor G. Jovin, MD</a> &amp; Dr. <a href="/dliebesk/">David S Liebeskind, MD, MBA</a> on the LASTE trial publication! Large core strokes of unrestricted size receiving thrombectomy have favorable patient outcomes to medical care alone. This reinforces the need to increase accessible Thrombectomy worldwide #LASTETrial
David S Liebeskind (@dliebesk) 's Twitter Profile Photo

Great to connect with so many friends and colleagues at ARISE II! Much to discuss on ICAD, ICH and the cerebral veins…with academia industry NIH FDA

Great to connect with so many friends and colleagues at ARISE II! 
Much to discuss on ICAD, ICH and the cerebral veins…with academia industry NIH FDA
David S Liebeskind (@dliebesk) 's Twitter Profile Photo

The history & future of all stroke treatment, encapsulated by Lou Caplan! Truly timeless! An honor to be cited back to back with my father in 1971 and then my collaterals article in 2003...for future generations to come! #Brainstorme

The history &amp; future of all stroke treatment, encapsulated by Lou Caplan! Truly timeless! An honor to be cited back to back with my father in 1971 and then my collaterals article in 2003...for future generations to come!
#Brainstorme
JCBFM (@_jcbfm) 's Twitter Profile Photo

🚨 Exciting news for the JCBFM community! 🚨 Dare to shape the future program of Brain & BrainPET 2025 that will take place in Seoul, South Korea? Submit your symposium proposals by October 20, 2024! 🌍🧠 iscbfm.memberclicks.net/symposia2025#!/ #ISCBFM #meeting #JCBFM @BRAINPET25

🚨 Exciting news for the JCBFM community! 🚨

Dare to shape the future program of Brain &amp; BrainPET 2025 that will take place in Seoul, South Korea?

Submit your symposium proposals by October 20, 2024! 🌍🧠

iscbfm.memberclicks.net/symposia2025#!/

#ISCBFM #meeting #JCBFM @BRAINPET25
David S Liebeskind (@dliebesk) 's Twitter Profile Photo

Join Brainstorme! an unparalleled event on Entrepreneurship in Brain Health on Saturday, October 5, 2024...stay posted on all details for release next week! #BrAInstorme

Join Brainstorme! an unparalleled event on Entrepreneurship in Brain Health on Saturday, October 5, 2024...stay posted on all details for release next week!
#BrAInstorme
BRAIN Conference (@brainconferenc1) 's Twitter Profile Photo

🧠 Only 2 months to go until the #BRAINConference!⚡ Join us for three brainpower-packed days as experts cover stroke, aneurysms, blockchain, glymphatics, ICAD, neuroinflammation, and the latest tech. 💡🧬 The programme is now live—check it out today! brainconference.co.uk/event/2024/web…

🧠 Only 2 months to go until the #BRAINConference!⚡

Join us for three brainpower-packed days as experts cover stroke, aneurysms, blockchain, glymphatics, ICAD, neuroinflammation, and the latest tech. 💡🧬 The programme is now live—check it out today!
brainconference.co.uk/event/2024/web…
David S Liebeskind (@dliebesk) 's Twitter Profile Photo

🚨 Final Countdown to Brainstorme! 🚨 Speakers: Entrepreneurs share insights on scaling brain health solutions. Startups: Hear cutting-edge brain tech startups. Interactive Panels: Build strategy in brain health. Networking: Investors, innovators and thought leaders. #BrAInstorme

🚨 Final Countdown to Brainstorme! 🚨
Speakers: Entrepreneurs share insights on scaling brain health solutions.
Startups: Hear cutting-edge brain tech startups.
Interactive Panels: Build strategy in brain health.
Networking: Investors, innovators and thought leaders.
#BrAInstorme
Tyler Cole, MD (@tylcole) 's Twitter Profile Photo

David S Liebeskind, MD, MBA asked me to share a few examples of problems on the ground in neurosurgery and my experience of trying to solve them in his new conference. Stop by tomorrow!

<a href="/dliebesk/">David S Liebeskind, MD, MBA</a> asked me to share a few examples of problems on the ground in neurosurgery and my experience of trying to solve them in his new conference. Stop by tomorrow!
David S Liebeskind (@dliebesk) 's Twitter Profile Photo

Thank you to everyone that contributed to the incredible success of our inaugural Brainstorme! event yesterday. Our launch of the Million Brains Initiative with our secure, cloud-based platform heralds a new era in precision medicine on a global scale. #brAInstorme

Thank you to everyone that contributed to the incredible success of our inaugural Brainstorme! event yesterday. Our launch of the Million Brains Initiative with our secure, cloud-based platform heralds a new era in precision medicine on a global scale.
#brAInstorme
David S Liebeskind (@dliebesk) 's Twitter Profile Photo

What a heated, vibrant discussion on endovascular therapy! Caught a "SLICE" of winter weather remotely from Buffalo today, but hard to get a word in! More RCTs not needed in large strokes - we have the most robust data from 6 RCTs, including detailed imaging. ENCORE! #Brainstorme

What a heated, vibrant discussion on endovascular therapy! Caught a "SLICE" of winter weather remotely from Buffalo today, but hard to get a word in! More RCTs not needed in large strokes - we have the most robust data from 6 RCTs, including detailed imaging. ENCORE!
#Brainstorme
David S Liebeskind (@dliebesk) 's Twitter Profile Photo

Off again to share a global worksgiving with colleagues and friends! In Seoul and London to enjoy a neurovascular smorgasbord of acute ischemic stroke, aneurysms, stenoses and much more with imaging...happy thanksgiving to all! #Brainstorme

AshuJadhav (@ashupjadhav) 's Twitter Profile Photo

Neurovascular Innovation at the FDA: Pivotal Strategies to Effectively Modernize the Realization of Diagnostic, Drug, and Device Products | Stroke: Vascular and Interventional Neurology ahajournals.org/doi/10.1161/SV… Stroke AHA/ASA SVIN Stroke: Vascular and Interventional Neurology

Neurovascular Innovation at the FDA: Pivotal Strategies to Effectively Modernize the Realization of Diagnostic, Drug, and Device Products | Stroke: Vascular and Interventional Neurology ahajournals.org/doi/10.1161/SV… <a href="/StrokeAHA_ASA/">Stroke AHA/ASA</a> <a href="/svinsociety/">SVIN</a> <a href="/SVINJournal/">Stroke: Vascular and Interventional Neurology</a>
David S Liebeskind (@dliebesk) 's Twitter Profile Photo

🧠💥 Time to Rethink Regulation in Stroke Care: Welcome to the NeuFDA Era 💥🧠 The FDA is evolving and so is our approach to advance neurovascular innovation. 📄 Read the posted article We are organizing an expert stakeholder coalition in September 2025. Stay tuned & connected!

🧠💥 Time to Rethink Regulation in Stroke Care: Welcome to the NeuFDA Era 💥🧠
The FDA is evolving and so is our approach to advance neurovascular innovation.
📄 Read the posted article
We are organizing an expert stakeholder coalition in September 2025. Stay tuned &amp; connected!